JOSHUA SILVERMAN

Corporate Board Profile

Tech Score: 0/100

AYRO, Inc.

Filing Date	Source Excerpt
2016-08-16	Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman’s extensive knowledge of the capital markets and experience serving in senior executive positions and on the board of directors of public companies well qualifies him for service on our board of directors.
2018-10-09	Mr. Silverman’s qualifications include experience as an investment banker, management consultant and director of numerous public companies.
2019-11-06	Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and as a director of numerous public companies.
2020-11-09	Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and as a director of numerous public companies.
2021-11-17	Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and as a director of numerous public companies.
2022-10-26	Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and director of numerous public companies.
2023-10-30	Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and director of numerous public companies.
2024-12-05	Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and director of numerous public companies.

FEMASYS INC

Filing Date	Source Excerpt
2024-06-07	Mr. Silverman received his B.A. from Lehigh University. Our Board believes that Mr. Silverman is qualified to serve on our Board due to his extensive experience in the life sciences creating new businesses, establishing strategic direction and fundraising, as well as his leadership experience.

Marker Therapeutics, Inc.

Filing Date	Source Excerpt
2017-07-12	Mr. Silverman received his B.A. from Lehigh University in 1992. In the past five years, Mr. Silverman has served on the boards of directors of Neurotrope, Inc., MGT Capital Investments Inc., National Holdings Corporation, Alanco Technologies Inc., Protagenic Therapeutics, Inc. and WPCS International Incorporated.

MGT CAPITAL INVESTMENTS, INC.

Filing Date	Source Excerpt
2014-11-05	Joshua Silverman 44 Director ...Joshua Silverman is the Co-founder, and is a Principal and Managing Partner of Iroquois Capital Management, LLC, the Registered Investment Advisor to Iroquois Capital LP and Iroquois Capital (Offshore) Ltd. (collectively, “Iroquois”). Mr. Silverman has served as Co-Chief Investment Officer of Iroquois since inception in 2003.
2015-11-19	Joshua Silverman joined the Company in 2014 as a director. He is the Co–founder, and is a Principal and Managing Partner of Iroquois Capital Management, LLC, the Registered Investment Advisor to Iroquois Capital LP and Iroquois Capital (Offshore) Ltd. (collectively, “Iroquois”). Mr. Silverman has served as Co–Chief Investment Officer of Iroquois since inception in 2003. From 2000 to 2003, Mr. Silverman served as Co–Chief Investment Officer of Vertical Ventures, LLC, a merchant bank. Prior to forming Iroquois, Mr. Silverman was a Director of Joele Frank, a boutique consulting firm specializing in mergers and acquisitions. Previously, Mr. Silverman served as Assistant Press Secretary to The President of The United States. Mr. Silverman received his B.A. from Lehigh University in 1992. Based on Mr. Silverman’s overall background and experience as an executive in the financial industry, Board believes that Mr. Silverman has the requisite experience, qualifications, attributes and skill necessary to serve as a member of the Board. Director Compensation for 2014 The following table sets forth the compensation of persons who served as a member of our Board of Directors during all or part of 2014, other than Robert B. Ladd, whose compensations is discussed under "Executive Compensation" above and who is not separately compensated for Board service. Name Fees earned or paid in cash Stock awards All other compensation Total Joshua Silverman $1 – – $1 Our policy is each independent director receives annual compensation of $20. In addition, independent directors, receive $5 as total compensation for committee service. The Chairman of the Board receives an additional $5.

Filing Date

Source Excerpt

2014-11-05

Joshua Silverman 44 Director ...Joshua Silverman is the Co-founder, and is a Principal and Managing Partner of Iroquois Capital Management, LLC, the Registered Investment Advisor to Iroquois Capital LP and Iroquois Capital (Offshore) Ltd. (collectively, “Iroquois”). Mr. Silverman has served as Co-Chief Investment Officer of Iroquois since inception in 2003.

2015-11-19

Joshua Silverman joined the Company in 2014 as a director. He is the Co–founder, and is a Principal and Managing Partner of Iroquois Capital Management, LLC, the Registered Investment Advisor to Iroquois Capital LP and Iroquois Capital (Offshore) Ltd. (collectively, “Iroquois”). Mr. Silverman has served as Co–Chief Investment Officer of Iroquois since inception in 2003. From 2000 to 2003, Mr. Silverman served as Co–Chief Investment Officer of Vertical Ventures, LLC, a merchant bank. Prior to forming Iroquois, Mr. Silverman was a Director of Joele Frank, a boutique consulting firm specializing in mergers and acquisitions. Previously, Mr. Silverman served as Assistant Press Secretary to The President of The United States. Mr. Silverman received his B.A. from Lehigh University in 1992. Based on Mr. Silverman’s overall background and experience as an executive in the financial industry, Board believes that Mr. Silverman has the requisite experience, qualifications, attributes and skill necessary to serve as a member of the Board. Director Compensation for 2014 The following table sets forth the compensation of persons who served as a member of our Board of Directors during all or part of 2014, other than Robert B. Ladd, whose compensations is discussed under "Executive Compensation" above and who is not separately compensated for Board service. Name Fees earned or paid in cash Stock awards All other compensation Total Joshua Silverman $1 – – $1 Our policy is each independent director receives annual compensation of $20. In addition, independent directors, receive $5 as total compensation for committee service. The Chairman of the Board receives an additional $5.

Protagenic Therapeutics, Inc.\new

Filing Date	Source Excerpt
2016-05-03	On April 15, 2016, we made the following option grants under the 2016 Plan. These grants will become void if the 2016 Plan is not approved by our stockholders: Joshua Silverman: 45,000 options at $1.25/share, vesting over 24 months
2018-06-13	Joshua Silverman, Director, joined us effective the closing of the Merger in February 2016. Mr. Silverman is the Co–founder and Managing Member of Parkfield Funding LLC, and is a former Principal and Managing Partner of Iroquois Capital Management, LLC. ... Mr. Silverman received his B.A. from Lehigh University in 1992.
2019-08-12	Joshua Silverman, Director, joined us effective the closing of the Merger in February 2016. ... Mr. Silverman brings to our Board years of experience in the financial arena, as well as significant public company experience. ... The Nominating and Corporate Governance Committee consists of Joshua Silverman (Chair), Garo Armen, Ph.D., and Robert Stein, Ph.D. ... During fiscal year 2018 we did not compensate directors who were not employees of the Company.
2020-08-28	Joshua Silverman, Director, joined us effective the closing of the Merger in February 2016. ... Mr. Silverman brings to our Board years of experience in the financial arena, as well as significant public company experience. ... The Compensation Committee consist of Khalil Barrage (Chairperson), Brian Corvese and Josh Silverman. ... The Nominating and Corporate Governance Committee consists of Joshua Silverman (Chair), Brian Corvese and Jennifer Buell, Ph.D. ... During fiscal year 2019 we did not compensate directors who were not employees of the Company.
2021-09-08	Joshua Silverman, Director, Mr. Silverman currently serves as the managing member of Parkfield Funding LLC. ... Mr. Silverman currently serves as a director of Akers Biosciences, Inc., AYRO, Inc., Protagenic Therapeutics, Petros Pharmaceuticals, Inc. and Synaptogenix, Inc. ... The Compensation Committee consist of Khalil Barrage (Chairperson), Brian Corvese and Josh Silverman. ... The Nominating and Corporate Governance Committee consists of Joshua Silverman (Chair), and Brian Corvese. ... During fiscal year 2020 we did not compensate directors who were not employees of the Company.

TNF Pharmaceuticals, Inc.

Filing Date	Source Excerpt
2018-11-14	Joshua Silverman currently serves as the Managing Member of Parkfield Funding LLC... Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman was selected to serve of the board of the Company in part because of his significant expertise in capital markets, corporate structure and management.
2019-02-05	Named Executive Officers and Directors: Joshua Silverman
2019-11-12	Mr. Silverman currently serves as the Managing Member of Parkfield Funding LLC. Mr. Silverman was the co-founder, and a Principal and Managing Partner of Iroquois Capital Management, LLC, an investment advisory firm. ... Mr. Silverman received his B.A. from Lehigh University in 1992.
2020-07-29	Mr. Silverman received his B.A. from Lehigh University in 1992.
2021-11-22	Mr. Silverman received his B.A. from Lehigh University in 1992.
2022-10-26	Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and as a director of numerous public companies.
2023-03-13	Joshua Silverman Chairman of the Board of Directors
2023-06-30	Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and as a director of numerous public companies.
2024-07-01	Joshua Silverman Chairman of the Board of Directors
2024-11-01	Mr. Silverman was the co-founder, and a principal and managing partner of Iroquois Capital Management, LLC... Mr. Silverman received his B.A. from Lehigh University in 1992.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22